As the CAC 40 Index in France shows modest gains amid hopes for more aggressive monetary easing by the European Central Bank, investors are increasingly looking at growth stocks with strong insider ownership as a potential area of interest. In this environment, companies where insiders hold significant stakes can be appealing because they often indicate confidence in the company's future prospects and alignment with shareholder interests.
Name | Insider Ownership | Earnings Growth |
Groupe OKwind Société anonyme (ENXTPA:ALOKW) | 20.6% | 36% |
VusionGroup (ENXTPA:VU) | 13.4% | 81.7% |
Icape Holding (ENXTPA:ALICA) | 30.2% | 33.9% |
Arcure (ENXTPA:ALCUR) | 21.4% | 26.6% |
STIF Société anonyme (ENXTPA:ALSTI) | 16.4% | 22.9% |
La Française de l'Energie (ENXTPA:FDE) | 19.9% | 31.9% |
S.M.A.I.O (ENXTPA:ALSMA) | 17.4% | 35.2% |
Adocia (ENXTPA:ADOC) | 11.7% | 64% |
Munic (ENXTPA:ALMUN) | 27.1% | 174.1% |
MedinCell (ENXTPA:MEDCL) | 15.8% | 93.9% |
Let's review some notable picks from our screened stocks.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Exclusive Networks SA is a global cybersecurity specialist focused on digital infrastructure with a market cap of €2.14 billion.
Operations: The company's revenue is segmented into three main regions: APAC with €480 million, EMEA with €4.19 billion, and the Americas contributing €705 million.
Insider Ownership: 13.1%
Exclusive Networks, a French cybersecurity firm, is currently undergoing a significant transition as Clayton, Dubilier & Rice and Permira plan to take it private in a €2.2 billion deal. The company has high insider ownership with 66.7% held by Permira and founder Olivier Breittmayer. Despite recent earnings showing reduced net income and profit margins, Exclusive Networks' revenue is forecasted to grow faster than the French market at 13.1% annually, with earnings expected to rise significantly at 33.5% per year.
Simply Wall St Growth Rating: ★★★★★☆
Overview: MedinCell S.A. is a pharmaceutical company based in France that focuses on developing long-acting injectables across various therapeutic areas, with a market cap of €456.09 million.
Operations: The company's revenue is primarily derived from its Pharmaceuticals segment, totaling €11.95 million.
Insider Ownership: 15.8%
MedinCell, a French pharmaceutical company, is experiencing notable growth potential with high insider ownership. The company's revenue is projected to grow significantly at 46.2% annually, outpacing the French market average. Despite negative shareholders' equity, MedinCell's earnings are forecasted to grow by 93.95% per year and it is expected to become profitable within three years. Recent strategic collaborations with AbbVie and Teva highlight its innovative BEPO® technology platform for long-acting injectables, promising substantial future milestones and royalties.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: OVH Groupe S.A. is a global provider of public and private cloud services, shared hosting, and dedicated server solutions, with a market cap of €1.29 billion.
Operations: The company's revenue is primarily derived from its Private Cloud segment at €589.61 million, followed by Public Cloud at €169.01 million, and Web cloud & Other services contributing €185.43 million.
Insider Ownership: 10.5%
OVH Groupe is forecast to achieve profitability within three years, with earnings expected to grow significantly at 101.37% annually. Its revenue growth of 9.7% per year surpasses the French market average of 5.6%. Despite trading at a substantial discount below its estimated fair value, OVH's return on equity is anticipated to remain low in the coming years. The company's share price has been highly volatile recently, and there are no substantial insider trading activities reported over the past three months.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com